We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDU icon
101
New Oriental
EDU
$8.08B
$25.2M 0.24%
168,716
-33,371
-17% -$4.82M
EXAS
102
DELISTED
Exact Sciences
EXAS
$24.7M 0.23%
242,580
+54,652
+29% +$4.72M
PDD icon
103
Pinduoduo
PDD
$122B
$24.6M 0.23%
332,400
-124,400
-27% -$10.7M
SRPT icon
104
Sarepta Therapeutics
SRPT
$1.63B
$24.6M 0.23%
174,829
– –
ALNY icon
105
Alnylam Pharmaceuticals
ALNY
$38.5B
$24.4M 0.23%
167,600
– –
PTC icon
106
PTC
PTC
$14.7B
$24.4M 0.23%
294,912
+14,667
+5% +$1.25M
XYL icon
107
Xylem
XYL
$29.2B
$24.4M 0.23%
289,995
+11,168
+4% +$869K
TENB icon
108
Tenable Holdings
TENB
$3.46B
$24.3M 0.23%
642,910
+112,691
+21% +$3.86M
KO icon
109
Coca-Cola
KO
$380B
$24.2M 0.23%
489,492
-73,660
-13% -$3.54M
MELI icon
110
Mercado Libre
MELI
$94.4B
$24.2M 0.23%
22,321
-5,603
-20% -$6.08M
BNTX icon
111
BioNTech
BNTX
$23.4B
$24.1M 0.23%
347,537
-62,776
-15% -$4.5M
VRNS icon
112
Varonis Systems
VRNS
$5.13B
$23.8M 0.22%
618,798
-122,199
-16% -$4.56M
CDNS icon
113
Cadence Design Systems
CDNS
$95.1B
$23.5M 0.22%
220,425
+13,071
+6% +$1.38M
ECL icon
114
Ecolab
ECL
$79.6B
$23.5M 0.22%
117,462
+20,328
+21% +$4.06M
SEDG icon
115
SolarEdge
SEDG
$2.44B
$23.2M 0.22%
97,308
+36,160
+59% +$6.95M
AMTD
116
DELISTED
TD Ameritrade Holding Corp
AMTD
$23.1M 0.22%
590,377
+165,907
+39% +$6.24M
TAL icon
117
TAL Education Group
TAL
$5.79B
$23.1M 0.22%
303,793
+205,610
+209% +$15.5M
BRK.B icon
118
Berkshire Hathaway Class B
BRK.B
$1.11T
$23.1M 0.22%
108,411
-5,160
-5% -$1.06M
C icon
119
Citigroup
C
$222B
$22.9M 0.21%
530,390
-180,852
-25% -$9.01M
CAT icon
120
Caterpillar
CAT
$387B
$22.6M 0.21%
151,688
+95,701
+171% +$13.4M
IOVA icon
121
Iovance Biotherapeutics
IOVA
$2.1B
$22.6M 0.21%
685,081
-72,575
-10% -$2.22M
TIF
122
DELISTED
Tiffany & Co.
TIF
$22.5M 0.21%
194,464
+930
+0.5% +$113K
GLIBA
123
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$22.5M 0.21%
+274,689
New +$21.7M
MRTX
124
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$22.1M 0.21%
133,137
+23,076
+21% +$3.16M
DRNA
125
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$21.8M 0.2%
1,209,206
-134,063
-10% -$2.78M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.